OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.510
-0.070 (-4.43%)
At close: Mar 27, 2026, 4:00 PM EDT
1.520
+0.010 (0.66%)
After-hours: Mar 27, 2026, 4:10 PM EDT
OmniAb Employees
OmniAb had 89 employees as of December 31, 2025. The number of employees decreased by 25 or -21.93% compared to the previous year.
Employees
89
Change (1Y)
-25
Growth (1Y)
-21.93%
Revenue / Employee
$209,730
Profits / Employee
-$727,854
Market Cap
218.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 89 | -25 | -21.93% |
| Dec 31, 2024 | 114 | 8 | 7.55% |
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Sep 30, 2022 | 93 | 23 | 32.86% |
| Jun 30, 2022 | 87 | 17 | 24.29% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Sep 30, 2021 | 70 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| Voyager Therapeutics | 141 |
| Alector | 103 |
| Editas Medicine | 87 |
| Keros Therapeutics | 78 |
| Cybin | 50 |
| Camp4 Therapeutics | 48 |
| Sol-Gel Technologies | 34 |
OABI News
- 23 days ago - OmniAb, Inc. (OABI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - Business Wire
- 4 weeks ago - OmniAb to Participate at the Leerink Partners Global Healthcare Conference - Business Wire
- 5 weeks ago - OmniAb to Report Fourth Quarter 2025 Financial Results on March 4 - Business Wire
- 3 months ago - OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript - Seeking Alpha
- 3 months ago - Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies - Business Wire
- 4 months ago - OmniAb to Hold OmniUltra Virtual Investor Event on December 15 - Business Wire
- 4 months ago - OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors - Business Wire